Dr Gordon F Schaye, MD | |
20911 Earl St Ste 340, Torrance, CA 90503-4355 | |
(310) 540-2111 | |
(310) 944-9295 |
Full Name | Dr Gordon F Schaye |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Location | 20911 Earl St Ste 340, Torrance, California |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1386601268 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | G14544 (California) | Primary |
Entity Name | Healthcare Partners Affiliates Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1659312593 PECOS PAC ID: 7315842002 Enrollment ID: O20031204001258 |
News Archive
Oraya Therapeutics, Inc. announced today that it is significantly expanding its presence in Europe, with Oraya Therapy being offered for the first time at a National Health Service hospital in the United Kingdom and at four prestigious university hospitals in Germany. Oraya Therapy is intended as a one-time, non-invasive treatment for wet Age-related Macular Degeneration, with the potential to maintain or enhance vision while significantly reducing the required number of anti-vascular endothelial growth factor (anti-VEGF) injections into the eye.
NuGEN Technologies, the provider of innovative RNA and DNA amplification and sample preparation technologies for breakthrough genomic analysis, today announced it has received the State of California cGMP (current Good Manufacturing Practices) certification following a rigorous audit process. NuGEN is one of the first sample preparation companies to receive this certification, which allows the company to manufacture and ship any of its products under cGMP compliance.
Can exposure to a single virus particle lead to infection or disease? Until now, solid proof has been lacking. Experimental research with insect larvae at Wageningen University and Simon Fraser University in Canada has shown that one virus particle is theoretically enough to cause infection and subsequent disease.
According to a systematic review of existing studies, to appear in the May 4 issue of the Journal of the American Medical Association, the surgical procedure known as an episiotomy, performed in up to 35 percent of U.S. vaginal births, usually provides no benefits.
› Verified 3 days ago
Entity Name | Beach Cities Ents |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1356612048 PECOS PAC ID: 3779748678 Enrollment ID: O20120627000199 |
News Archive
Oraya Therapeutics, Inc. announced today that it is significantly expanding its presence in Europe, with Oraya Therapy being offered for the first time at a National Health Service hospital in the United Kingdom and at four prestigious university hospitals in Germany. Oraya Therapy is intended as a one-time, non-invasive treatment for wet Age-related Macular Degeneration, with the potential to maintain or enhance vision while significantly reducing the required number of anti-vascular endothelial growth factor (anti-VEGF) injections into the eye.
NuGEN Technologies, the provider of innovative RNA and DNA amplification and sample preparation technologies for breakthrough genomic analysis, today announced it has received the State of California cGMP (current Good Manufacturing Practices) certification following a rigorous audit process. NuGEN is one of the first sample preparation companies to receive this certification, which allows the company to manufacture and ship any of its products under cGMP compliance.
Can exposure to a single virus particle lead to infection or disease? Until now, solid proof has been lacking. Experimental research with insect larvae at Wageningen University and Simon Fraser University in Canada has shown that one virus particle is theoretically enough to cause infection and subsequent disease.
According to a systematic review of existing studies, to appear in the May 4 issue of the Journal of the American Medical Association, the surgical procedure known as an episiotomy, performed in up to 35 percent of U.S. vaginal births, usually provides no benefits.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Gordon F Schaye, MD 58 Portuguese Bend Rd, Rolling Hills, CA 90274-5070 Ph: (310) 541-3757 | Dr Gordon F Schaye, MD 20911 Earl St Ste 340, Torrance, CA 90503-4355 Ph: (310) 540-2111 |
News Archive
Oraya Therapeutics, Inc. announced today that it is significantly expanding its presence in Europe, with Oraya Therapy being offered for the first time at a National Health Service hospital in the United Kingdom and at four prestigious university hospitals in Germany. Oraya Therapy is intended as a one-time, non-invasive treatment for wet Age-related Macular Degeneration, with the potential to maintain or enhance vision while significantly reducing the required number of anti-vascular endothelial growth factor (anti-VEGF) injections into the eye.
NuGEN Technologies, the provider of innovative RNA and DNA amplification and sample preparation technologies for breakthrough genomic analysis, today announced it has received the State of California cGMP (current Good Manufacturing Practices) certification following a rigorous audit process. NuGEN is one of the first sample preparation companies to receive this certification, which allows the company to manufacture and ship any of its products under cGMP compliance.
Can exposure to a single virus particle lead to infection or disease? Until now, solid proof has been lacking. Experimental research with insect larvae at Wageningen University and Simon Fraser University in Canada has shown that one virus particle is theoretically enough to cause infection and subsequent disease.
According to a systematic review of existing studies, to appear in the May 4 issue of the Journal of the American Medical Association, the surgical procedure known as an episiotomy, performed in up to 35 percent of U.S. vaginal births, usually provides no benefits.
› Verified 3 days ago
Dr. Alexander Gertel, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 23550 Hawthorne Blvd Ste 125, Torrance, CA 90505 Phone: 310-891-6733 Fax: 310-257-7288 | |
David Sehwan Kim, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 23550 Hawthorne Blvd Ste 125, Torrance, CA 90505 Phone: 310-891-6733 Fax: 310-517-1348 | |
Dr. Brett A Levine, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 21320 Hawthorne Blvd, Suite 119, Torrance, CA 90503 Phone: 310-543-2313 Fax: 310-944-9295 | |
Steven E Davis, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 20911 Earl St, Suite #470, Torrance, CA 90503 Phone: 310-372-0700 Fax: 310-372-0774 | |
Janice Erica Chang, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 23550 Hawthorne Blvd Ste 180, Torrance, CA 90505 Phone: 310-465-2255 Fax: 310-465-2265 | |
Dr. Lesley Joel Luk, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4201 Torrance Blvd, Suite 390, Torrance, CA 90503 Phone: 310-540-0018 Fax: 310-540-4988 | |
Mike Sheu, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 23441 Madison St, Building 8, Suite 130, Torrance, CA 90505 Phone: 310-791-2233 |